Also trades as: ERIS.BO (BSE) · $vol 0M

₹1,189.80 ($12.37)

+0.00 (+0.00%)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 29 · ₹165.0B mcap · 44M float · 0.193% daily turnover

Revenue

$31.3B +8.7% ▲

5Y CAGR: +21.3%

Gross Profit

$15.0B -30.3% ▼

5Y CAGR: +9.5%

Operating Income

$8.4B +19.5% ▲

5Y CAGR: +16.2%

Net Income

$6.2B +76.1% ▲

5Y CAGR: +11.8%

EPS (Diluted)

$45.33 +75.6% ▲

5Y CAGR: +11.6%

EBITDA

$11.1B +7.3% ▲

5Y CAGR: +20.4%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$13.3B	$16.6B	$19.9B	$28.8B	$31.3B
YoY Growth	+11.2%	+25.3%	+19.8%	+44.6%	+8.7%
Cost of Revenue	$2.6B	$3.5B	$10.0B	$7.3B	$16.3B
Gross Profit	$10.7B	$13.1B	$9.9B	$21.5B	$15.0B
Gross Margin	80.3%	78.8%	49.9%	74.6%	47.9%
R&D Expenses	$327M	$61M	$57M	$24M	$0
SG&A Expenses	$1.5B	$3.5B	$2.5B	$5.3B	$6.6B
Operating Expenses	$6.4B	$3.6B	$4.9B	$5.3B	$6.6B
Operating Income	$4.3B	$4.3B	$5.0B	$16.6B	$8.4B
Operating Margin	32.5%	25.8%	24.9%	57.7%	26.9%
Interest Expense	$42M	$262M	$848M	$2.3B	$1.9B
Income Before Tax	$4.4B	$4.0B	$4.3B	$4.9B	$6.4B
Tax Expense	$364M	$305M	$342M	$1.1B	-$90M
Net Income	$4.1B	$3.8B	$3.9B	$3.5B	$6.2B
Net Margin	30.6%	23.0%	19.7%	12.2%	19.8%
EPS (Diluted)	$29.88	$28.07	$28.79	$25.81	$45.33
EBITDA	$5.1B	$5.5B	$7.0B	$10.2B	$11.1B
Shares Outstanding	136M	136M	136M	136M	137M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$7.2B	$7.4B	$7.2B	$7.0B	$7.7B	$7.9B	$8.0B	$7.7B
Cost of Revenue	$3.9B	$3.9B	$1.8B	$1.9B	$1.8B	$2.0B	$2.2B	$10.2B
Gross Profit	$3.3B	$3.5B	$5.5B	$5.2B	$5.9B	$5.9B	$5.8B	-$2.5B
Gross Margin	45.9%	47.1%	75.5%	73.5%	76.1%	74.4%	72.1%	-33.2%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$1.6B	$1.6B	$0	$1.4B	$1.4B	$0	$0	$1.6B
Operating Expenses	$1.6B	$1.6B	$3.8B	$3.4B	$3.8B	$3.7B	$3.7B	-$4.6B
Operating Income	$1.7B	$1.8B	$1.7B	$1.8B	$2.1B	$2.2B	$2.1B	$2.0B
Operating Margin	24.2%	24.8%	23.4%	25.1%	26.7%	27.7%	26.4%	26.6%
Interest Expense	$604M	$595M	$572M	$543M	$487M	$496M	$488M	$456M
Income Before Tax	$1.2B	$1.3B	$1.2B	$1.3B	$1.6B	$1.7B	$1.5B	$1.6B
Tax Expense	$259M	$328M	$292M	$263M	$360M	$382M	$365M	-$1.2B
Net Income	$832M	$916M	$836M	$934M	$1.2B	$1.2B	$997M	$2.8B
Net Margin	11.6%	12.4%	11.6%	13.3%	15.3%	15.2%	12.5%	36.7%
EPS (Diluted)	$6.10	$6.72	$6.14	$6.89	$8.64	$8.81	$7.32	$20.60
EBITDA	$2.5B	$2.7B	$2.5B	$2.6B	$2.8B	$2.9B	$2.6B	$2.7B
Shares Outstanding	136M	136M	136M	136M	137M	136M	136M	137M

ERIS.NS NSE